214 related articles for article (PubMed ID: 24572783)
41. Axonal transport of AAV9 in nonhuman primate brain.
Green F; Samaranch L; Zhang HS; Manning-Bog A; Meyer K; Forsayeth J; Bankiewicz KS
Gene Ther; 2016 Jun; 23(6):520-6. PubMed ID: 26953486
[TBL] [Abstract][Full Text] [Related]
42. Intra-ventricular infusion of rAAV1-EGFP resulted in transduction in multiple regions of adult rat brain: a comparative study with rAAV2 and rAAV5 vectors.
Li SF; Wang RZ; Meng QH; Li GL; Hu GJ; Dou WC; Li ZJ; Zhang ZX
Brain Res; 2006 Nov; 1122(1):1-9. PubMed ID: 17045577
[TBL] [Abstract][Full Text] [Related]
43. Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna.
Hinderer C; Bell P; Vite CH; Louboutin JP; Grant R; Bote E; Yu H; Pukenas B; Hurst R; Wilson JM
Mol Ther Methods Clin Dev; 2014; 1():14051. PubMed ID: 26052519
[TBL] [Abstract][Full Text] [Related]
44. Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9.
Masamizu Y; Okada T; Kawasaki K; Ishibashi H; Yuasa S; Takeda S; Hasegawa I; Nakahara K
Neuroscience; 2011 Oct; 193():249-58. PubMed ID: 21782903
[TBL] [Abstract][Full Text] [Related]
45. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
[TBL] [Abstract][Full Text] [Related]
46. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
[TBL] [Abstract][Full Text] [Related]
47. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
48. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
49. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.
Fu H; Muenzer J; Samulski RJ; Breese G; Sifford J; Zeng X; McCarty DM
Mol Ther; 2003 Dec; 8(6):911-7. PubMed ID: 14664793
[TBL] [Abstract][Full Text] [Related]
50. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
Wang C; Wang CM; Clark KR; Sferra TJ
Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
[TBL] [Abstract][Full Text] [Related]
51. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
[TBL] [Abstract][Full Text] [Related]
52. Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice.
Tanguy Y; Biferi MG; Besse A; Astord S; Cohen-Tannoudji M; Marais T; Barkats M
Front Mol Neurosci; 2015; 8():36. PubMed ID: 26283910
[TBL] [Abstract][Full Text] [Related]
53. Assessment of AAV9 distribution and transduction in rats after administration through Intrastriatal, Intracisterna magna and Lumbar Intrathecal routes.
Chandran J; Chowdhury EA; Perkinton M; Jamier T; Sutton D; Wu S; Dobson C; Shah DK; Chessell I; Meno-Tetang GML
Gene Ther; 2023 Feb; 30(1-2):132-141. PubMed ID: 35637286
[TBL] [Abstract][Full Text] [Related]
54. Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
Bey K; Deniaud J; Dubreil L; Joussemet B; Cristini J; Ciron C; Hordeaux J; Le Boulc'h M; Marche K; Maquigneau M; Guilbaud M; Moreau R; Larcher T; Deschamps JY; Fusellier M; Blouin V; Sevin C; Cartier N; Adjali O; Aubourg P; Moullier P; Colle MA
Mol Ther Methods Clin Dev; 2020 Jun; 17():771-784. PubMed ID: 32355866
[TBL] [Abstract][Full Text] [Related]
55. AAV8(gfp) preferentially targets large diameter dorsal root ganglion neurones after both intra-dorsal root ganglion and intrathecal injection.
Jacques SJ; Ahmed Z; Forbes A; Douglas MR; Vigenswara V; Berry M; Logan A
Mol Cell Neurosci; 2012 Apr; 49(4):464-74. PubMed ID: 22425560
[TBL] [Abstract][Full Text] [Related]
56. Selective Neuronal Uptake and Distribution of AAVrh8, AAV9, and AAVrh10 in Sheep After Intra-Striatal Administration.
Mondo E; Moser R; Gao G; Mueller C; Sena-Esteves M; Sapp E; Pfister E; O'Connell D; Takle K; Erger KE; Liu W; Conlon TJ; DiFiglia M; Gounis MJ; Aronin N
J Huntingtons Dis; 2018; 7(4):309-319. PubMed ID: 30320596
[TBL] [Abstract][Full Text] [Related]
57. Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons.
Foust KD; Poirier A; Pacak CA; Mandel RJ; Flotte TR
Hum Gene Ther; 2008 Jan; 19(1):61-70. PubMed ID: 18052722
[TBL] [Abstract][Full Text] [Related]
58. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
59. Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain.
San Sebastian W; Samaranch L; Heller G; Kells AP; Bringas J; Pivirotto P; Forsayeth J; Bankiewicz KS
Gene Ther; 2013 Dec; 20(12):1178-83. PubMed ID: 24067867
[TBL] [Abstract][Full Text] [Related]
60. Systemic AAV6-synapsin-GFP administration results in lower liver biodistribution, compared to AAV1&2 and AAV9, with neuronal expression following ultrasound-mediated brain delivery.
Weber-Adrian D; Kofoed RH; Silburt J; Noroozian Z; Shah K; Burgess A; Rideout S; Kügler S; Hynynen K; Aubert I
Sci Rep; 2021 Jan; 11(1):1934. PubMed ID: 33479314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
